Clinical Trials
95 trialsFollow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
National Institutes of Health Clinical Center (CC)
RF-2018-123683
IRCCS San Raffaele
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Massachusetts General Hospital
TA-P-OLIM
University Hospital, Ghent
DP-04
AstraZeneca
EVENTIDE
University of Aberdeen
Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
CLIQQC
Société Algérienne de Formation et Recherche en Oncologie
PPSARP
Lithuanian University of Health Sciences
METAGIO
Bristol-Myers Squibb
BACAP-2
University Hospital, Toulouse
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
Astellas Pharma Inc
PRIAPUS-PCa
CancerCare Manitoba
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
ABRUPT 2
University of Milano Bicocca
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Stanford University
X-SMILE
University of Zurich
LUDOPATH
Jules Bordet Institute
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
TScan Therapeutics, Inc.
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
Pan-tumor MRD Study
Paradigm Health
POELH-II
Erasmus Medical Center
HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia
AstraZeneca
PCW
Wake Forest University Health Sciences
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations
Telix Pharmaceuticals (Innovations) Pty Limited
MINIONS
European Institute of Oncology
TRACT DNA
Medical College of Wisconsin
PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy
Institute of Cancer Research, United Kingdom
BACAP
University Hospital, Toulouse
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Osteosclerotic Changes on CT Predict Survival in Prostate Cancer
Sun Yat-sen University
SERPAN
Centre Hospitalier Universitaire de Saint Etienne
RegisterPROS
Wren Laboratories LLC
ProA
Sun Yat-sen University
SPACE
Carol Davila University of Medicine and Pharmacy
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
The First Affiliated Hospital with Nanjing Medical University
Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer
Heinrich-Heine University, Duesseldorf
Genetic Studies of Prostate Cancer Aggressiveness and Prognosis
Karolinska Institutet
Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions
IRCCS Azienda Ospedaliero-Universitaria di Bologna
ROOT
Taproot Health
Investigation of the Diagnostic Role of miRNAs in PCa and BPH
Alanya Alaaddin Keykubat University
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
Memorial Sloan Kettering Cancer Center
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
University Hospital, Basel, Switzerland
MIMETIC
European Institute of Oncology
BANN
University Medical Center Groningen
YOUNGSTER
European Institute of Oncology
Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia
Daiichi Sankyo
HCC and FTC
The Catholic University of Korea